NEVRO CORP. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 35 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-12-29: Reporting owner Elghandour Rami; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-12-29: Reporting owner Galligan Andrew H; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-12-17: Reporting owner Walker Andre; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-12-14: Reporting owner Walker Andre; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-12-29 | Elghandour Rami Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +485 130,390 owned after | $3.60 exercise price | 2016-03-11 | |
| 2015-12-29 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,500 72,904 owned after | $1.44 exercise price | 2016-03-03 | |
| 2015-12-17 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13 47,409 owned after | $1.44 exercise price | 2015-12-18 | |
| 2015-12-14 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 47,422 owned after | $1.44 exercise price | 2015-12-16 | |
| 2015-12-10 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −302 0 owned after | $0.96 exercise price | 2015-12-14 | |
| 2015-12-10 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −312 0 owned after | $0.96 exercise price | 2015-12-14 | |
| 2015-12-10 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 50,422 owned after | $1.44 exercise price | 2015-12-14 | |
| 2015-12-07 | Elghandour Rami Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 130,875 owned after | $3.60 exercise price | 2015-12-09 | |
| 2015-12-02 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 302 owned after | $0.96 exercise price | 2015-12-04 | |
| 2015-12-01 | Alleavitch Doug Officer (VP, Quality and Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,000 21,000 owned after | $63.23 exercise price | 2015-12-03 | |
| 2015-12-01 | Enxing Michael Officer (VP of Sales & Marketing) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,300 13,300 owned after | $63.23 exercise price | 2015-12-03 | |
| 2015-12-01 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,500 44,500 owned after | $63.23 exercise price | 2015-12-03 | |
| 2015-12-01 | DEMANE MICHAEL F Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $63.23 exercise price | 2015-12-03 | |
| 2015-12-01 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 1,302 owned after | $0.96 exercise price | 2015-12-02 | |
| 2015-12-01 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $63.23 exercise price | 2015-12-02 | |
| 2015-12-01 | Elghandour Rami Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +49,500 49,500 owned after | $63.23 exercise price | 2015-12-02 | |
| 2015-11-30 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 3,302 owned after | $0.96 exercise price | 2015-12-02 | |
| 2015-11-30 | Elghandour Rami Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 134,375 owned after | $3.60 exercise price | 2015-12-02 | |
| 2015-11-24 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 9,302 owned after | $0.96 exercise price | 2015-11-25 | |
| 2015-11-23 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 10,302 owned after | $0.96 exercise price | 2015-11-24 | |
| 2015-11-17 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,446 77,404 owned after | $1.44 exercise price | 2015-11-19 | |
| 2015-11-17 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −869 62,940 owned after | $3.60 exercise price | 2015-11-19 | |
| 2015-11-17 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,070 44,804 owned after | $3.60 exercise price | 2015-11-19 | |
| 2015-11-17 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,615 51,899 owned after | $18.00 exercise price | 2015-11-19 | |
| 2015-09-17 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 11,302 owned after | $0.96 exercise price | 2015-09-21 | |
| 2015-06-29 | Earnhardt Lisa D Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,853 5,853 owned after | $53.59 exercise price | 2015-07-01 | |
| 2015-05-28 | Behbahani Ali Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,182 4,182 owned after | $50.50 exercise price | 2015-06-01 | |
| 2015-05-28 | PLIAM NATHAN B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,182 4,182 owned after | $50.50 exercise price | 2015-06-01 | |
| 2015-05-28 | McCormick Shawn Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,182 4,182 owned after | $50.50 exercise price | 2015-06-01 | |
| 2015-05-28 | JAEGER WILFRED E Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,182 4,182 owned after | $50.50 exercise price | 2015-06-01 | |
| 2015-05-28 | Fischer Frank M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,182 4,182 owned after | $50.50 exercise price | 2015-06-01 | |
| 2015-05-28 | Vale Brad Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,182 4,182 owned after | $50.50 exercise price | 2015-06-01 | |
| 2015-04-10 | Alleavitch Doug Officer (VP, Quality and Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,500 36,500 owned after | $53.70 exercise price | 2015-04-13 | |
| 2015-03-01 | Vale Brad Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,749 8,749 owned after | $41.83 exercise price | 2015-03-04 | |
| 2015-01-13 | Shankar Balakrishnan Officer (VP, Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,257 28,257 owned after | $38.79 exercise price | 2015-01-15 |